C4 Therapeutics, Inc. - Common Stock — datos financieros trimestrales (NASDAQ:CCCC) | MetaTrader

Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas

Flujo de caja de las actividades operativas -17.93 M-33.28 M-12.06 M-31.21 M-22.14 M-29.94 M -95.35 M Flujo de caja de las actividades de inversión 13.67 M29.13 M38.92 M4.09 M-80.73 M16.15 M -21.57 M Flujo de caja de las actividades financieras 112 K-46 K07.77 M118.67 M462 K 126.91 M Flujo de caja libre -17.93 M-33.28 M-12.24 M-31.62 M-22.16 M-30.01 M -96.02 M

Noticias

Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year?

C4 Therapeutics, Inc. (CCCC) Reports Q1 Loss, Lags Revenue Estimates

LENZ Therapeutics, Inc. (LENZ) Reports Q1 Loss, Beats Revenue Estimates

Dianthus Therapeutics, Inc. (DNTH) Reports Q1 Loss, Lags Revenue Estimates

C4 Therapeutics actualiza estatutos para designar tribunales federales como foros exclusivos

What's Going On With C4 Therapeutics Stock Thursday? - C4 Therapeutics (NASDAQ:CCCC)

Las acciones de C4 Therapeutics suben por ampliación de asociación con Roche

Is C4 Therapeutics (CCCC) Stock Outpacing Its Medical Peers This Year?

C4 Therapeutics inicia ensayo de cemsidomida con elranatamab

Are You Looking for a Top Momentum Pick? Why C4 Therapeutics, Inc. (CCCC) is a Great Choice

Is BrightSpring Health Services, Inc. (BTSG) Stock Outpacing Its Medical Peers This Year?

Barclays eleva el precio objetivo de C4 Therapeutics por avances en ensayos